SOURCE: Cord Blood America, Inc.

April 13, 2005 09:09 ET

Cord Blood America to Present at the Cinapsys Microcap Conference Series

LOS ANGELES, CA -- (MARKET WIRE) -- April 13, 2005 -- Cord Blood America, Inc. (OTC BB: CBAI), an umbilical cord blood stem cell preservation company, announced that Matthew Schissler, Chairman and Chief Executive Officer, will present an overview of the Company's progress and strategy at the Cinapsys Microcap Conference on Saturday, April 16, 2005, at 8:30 a.m. PDT at the Sutton Place Hotel in Newport Beach, California.

Specifically, Matthew Schissler will discuss Cord Blood America's progress in private stem cell storage, and their future business strategies involving stem cells cultivated from the umbilical cord. Cinapsys will not be providing a webcast.

About Cord Blood America

Cord Blood America (OTC BB: CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood banking for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments, including cancer, leukemia, or blood and immune disorders. For more information on how this precious lifeline can benefit your family, visit www.cordpartners.com. For investor information, visit www.cordblood-america.com or call 1-888-882-CORD.

Forward-Looking Statements

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional cord blood banking revenue streams. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.

Contact Information